ClassID:

94924

C07D303/14 - CPC Classification

Classification description:

Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom; Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals

Recent Application in this class:
#1
20250263763
2025-08-21

PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS

#2
20240132460
2024-04-25

SYNTHESIS OF TIGILANOL TIGLATE AND ANALOGS THEREOF

#3
20230301960
2023-09-28

Tiglien-3-one derivatives

#4
20220411362
2022-12-29

DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)

#5
20220324806
2022-10-13

Cannabinoid derivatives

#6
20220144741
2022-05-12

Compound and composition

#7
20220041535
2022-02-10

Phenol derivative, and preparation process and use thereof

#8
20210196668
2021-07-01

TIGLIEN-3-ONE DERIVATIVES

#9
20210017142
2021-01-21

Process for the preparation of glycidol

#10
20200255390
2020-08-13

Entecavir intermediate, synthetic method thereof and synthetic method for entecavir

#11
20200179325
2020-06-11

Tiglien-3-one derivatives

#12
20200002261
2020-01-02

METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG

#13
20190099397
2019-04-04

Tiglien-3-one derivatives

#14
20180319756
2018-11-08

Glycidol synthesis method

#15
20180284077
2018-10-04

Methods for analysis and resolution of preparations of dianhydrogalactitol and derivatives or analogs thereof

#16
20180235925
2018-08-23

BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE

#17
20180147178
2018-05-31

COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL

#18
20180141889
2018-05-24

Methods of synthesizing a prostacyclin analog

#19
20180086727
2018-03-29

Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors

#20
20180023001
2018-01-25

COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE

#21
20170297995
2017-10-19

Methods of synthesizing a prostacyclin analog

#22
20170233356
2017-08-17

NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS

#23
20160326127
2016-11-10

NEUROACTIVE SUBSTITUTED CYCLOPENTA[b]PHENANTHRENES AS MODULATORS FOR GABA TYPE-A RECEPTORS

#24
20160311761
2016-10-27

Docosahexaenoyl ethanolamides

#25
20160296494
2016-10-13

Dihydroorotic and acid dehydrogenase inhibitor

#26
20160158187
2016-06-09

Tiglien-3-one derivatives

#27
20150362837
2015-12-17

Monomer, hardmask composition comprising monomer, and pattern forming method using hardmask composition

#28
20150329511
2015-11-19

Method of synthesis of substituted hexitols such as dianhydrogalactitol

#29
20150307467
2015-10-29

Norbornene derivative

#30
20150297553
2015-10-22

Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol

#31
20150038566
2015-02-05

Regulation of cholesterol homeostasis

#32
20150025257
2015-01-22

Docosahexaenoyl ethanolamides

#33
20140275241
2014-09-18

Neuroactive substituted cyclopent[]anthracenes as modulators for GABA type-A receptors

#34
20140248263
2014-09-04

BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE

#35
20140161764
2014-06-12

Compositions and methods to attract the brown marmorated stink bug (BMSB),

#36
20140155479
2014-06-05

Tiglien-3-one derivatives

#37
20140066642
2014-03-06

Method of synthesis of substituted hexitols such as dianhydrogalactitol

#38
20130274327
2013-10-17

Anti-inflammatory metabolite derived from omega-3-type fatty acid

#39
20130217798
2013-08-22

Methods of preparing hydroxy functional animal fats

#40
20130143228
2013-06-06

Activity based probes (ABPs) interacting with glycosidases

#41
20120289723
2012-11-15

METHOD FOR PREPARING INDENE DERIVATIVES, AND INTERMEDIATES FOR PREPARATION OF DERIVATIVES

#42
20120178949
2012-07-12

Preparation of an active intermediate

#43
20120088827
2012-04-12

Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)

#44
20120046357
2012-02-23

Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)

#45
20110295019
2011-12-01

Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes

#46
20110251411
2011-10-13

Preparation of an active intermediate

#47
20110251068
2011-10-13

PARASITIC PLANT CONTROL AGENT AND PARASITIC PLANT CONTROL METHOD

#48
20110136901
2011-06-09

Derivatives of 4-nerolidylcatechol, pharmaceutical compositions comprising them and process for producing the same

#49
20110082194
2011-04-07

Synergistic anticoagulant composition

#50
20100322991
2010-12-23

Honokiol analogs and their use in treating cancers

#51
20100298168
2010-11-25

Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions

#52
20100248264
2010-09-30

Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions

#53
20100204490
2010-08-12

Process for total synthesis of pladienolide B and pladienolide D

#54
20100152286
2010-06-17

Method for producing fucoxanthin

#55
20100113807
2010-05-06

Solid phase reaction system for oxidation

#56
20100094041
2010-04-15

ANTI-INFLAMMATORY AND PSORIASIS TREATMENT AND PROTEIN KINASE INHIBITION BY HYDROXY STILBENES AND NOVEL STILBENE DERIVATIVES AND ANALOGUES

#57
20090234000
2009-09-17

Triptolide analogs for the treatment of autoimmune and inflammatory disorders

#58
20090182042
2009-07-16

Tiglien-3-one derivatives

#59
20090177002
2009-07-09

Method For Preparing Indene Derivatives, And Intermediates For Preparation Of Derivatives

#60
20090159841
2009-06-25

Recovery of Optically Active Epoxy Alcohols

#61
20080255245
2008-10-16

Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxystilbenes and Novel Stilbene Derivatives and Analogues

#62
20080188548
2008-08-07

Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof

#63
20080139666
2008-06-12

Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues

#64
20080021226
2008-01-24

Process for total synthesis of pladienolide B and pladienolide D

#65
20070287843
2007-12-13

Methods and Intermediates for the Synthesis of Delta-9 Tetrahydrocannabinol

#66
20070203347
2007-08-30

Catalytic asymmetric epoxidation

#67
20070117993
2007-05-24

Multicomponent oxidation catalyst and process for producing epoxy compound therewith

#68
20060224019
2006-10-05

Process for the preparation of ketones by ozonolysis

#69
20060106242
2006-05-18

Intermediates for synthesis of vitamin D derivatives

#70
20060051879
2006-03-09

Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions

#71
20060040907
2006-02-23

Triptolide analogs for the treatment of autoimmune and inflammatory disorders

#72
20050250752
2005-11-10

Cembranoids with chemopreventive activity

#73
20050239878
2005-10-27

Inhibitors of methionine aminopeptidase-2 and uses thereof

#74
20050159607
2005-07-21

Catalytic asymmetric epoxidation

#75
20050059733
2005-03-17

Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues

#76
20050042771
2005-02-24

Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions

#77
13961659
2014-10-21

Regulation of cholesterol homeostasis